InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: 5TOP post# 7582

Thursday, 11/24/2016 2:33:26 AM

Thursday, November 24, 2016 2:33:26 AM

Post# of 233152
I like your thought process 5TOP. Many questions come to mind as to our inability to complete enrollment considering Pro-140's benefits in terms of efficacy and zero side effects. IMO P3 Adjuct protocol was more complicated and restrictive than we understand as investors not privi to the facts. We may very well be on the cusp of very good news in terms of enrollment on both Adjuct and Mono P3's given the FDA's willingness to support Pro-140's approval path.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News